Close Menu

One of the current stand-ins for personalized medicine is ethnicity, as people with different ancestral backgrounds can have varying risks for disease. However, a recent study led by researchers at Mount Sinai School of Medicine in New York found that "in the genomic era, conventional racial/ethnic labels are of little value" when translated to the clinic.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.